Good Review Practices (GRP) For The Medical Cannabis Industry

February 14, 2018

GRP is documented in the Center for Drug Evaluation and Research (CDER) that describes the process, format, content and/or management of a product review. And that could include medical cannabis

GRP’s were developed as guidance’s for review staff or as manuals of policies and procedures (MAPPs). An example of GRP is MAPP 6010.3 Rev.1 Good Review Practice: Clinical Review Template. This is a standard clinical review template describing the format and content of a new drug application review. GRP policies are updated regularly as advances are being made in science, statutes update, regulations change, and accumulated experience are gathered.

GRPs are developed over time as superior practices based on CDER’s collective experience to provide consistency to the overall review process of new products. GRPs are developed to improve the quality of reviews and review management. GRPs improve efficiency, clarity, and transparency of the review process and review management. GRPs are expected to be adopted by review staff as standard processes through supervisor mentoring, implementation teams, and formal training when necessary.

GRP collaborates policies from various offices within the CDER which include
  • Review Management
  • Biometrics
  • Clinical
  • Clinical Pharmacology
  • Non Prescription‎ Products
  • Safety
  • Chemistry
  • Manufacturing
  • Pharmacology/Toxicology

GRPs fundamental values are quality, efficiency, clarity, transparency and consistency.

If you want to read the full original article, and get some more in-depth details regarding best practices for the cannabis industry, please click here.

[Image credit: Pixabay]

The post Good Review Practices (GRP) For The Medical Cannabis Industry appeared first on Cannadelics.





Also in Education

Another Study Says Legalizations Don’t Increase Cannabis Use

August 07, 2022

The line is old and never made sense in the first place, but politician after politician like to extol the fear that if they legalize cannabis, everyone will become a pothead. As it turns out, study after study say the opposite, that legalizations don’t increase cannabis use, particularly in younger populations. Take a look. Yet […]

The post Another Study Says Legalizations Don’t Increase Cannabis Use appeared first on Cannadelics.

Continue Reading

Switzerland Implements Wide-Reaching Medical Cannabis Program

August 07, 2022

All eyes are on Switzerland as the country makes big moves to start its own cannabis industry. The country announced plans for a recreational measure last year, and now Switzerland is introducing a wide-reaching medical program that goes far beyond its previous limits. Switzerland is on a rampage, both widening its medical cannabis program, and […]

The post Switzerland Implements Wide-Reaching Medical Cannabis Program appeared first on Cannadelics.

Continue Reading

How Popular Are Psychedelics In America? Survey Says ~30% Have Tried

August 05, 2022

The psychedelics industry is gearing up for a massive debut, and opinions on the compounds are changing for the better. How popular are psychedelics in America right now? New survey results show that these compounds are not unknown to the American public, and that close to 30% of respondents, have already tried them. With the […]

The post How Popular Are Psychedelics In America? Survey Says ~30% Have Tried appeared first on Cannadelics.

Continue Reading

Summer Savings Sale